Subarachnoid Hemorrhage and Hormonal Factors in Women: A Population-Based Case-Control Study

Unlike most other types of cerebrovascular disease, aneurysmal subarachnoid hemorrhage occurs more frequently in women than in men [1, 2]. The explanation for this imbalance is unknown but is probably not related to currently recognized risk factors for subarachnoid hemorrhage [1-3], including cigarette smoking, use of alcohol, and history of hypertension, all of which are more common in men than in women [4-6]. To find other associations that could explain the sex difference, we examined hormonal factors among women included in a population-based casecontrol study of subarachnoid hemorrhage [3]. Methods As previously described [3], we recruited participants for a population-based casecontrol study of risk factors for subarachnoid hemorrhage in King County, Washington, between 1 July 1987 and 30 June 1989. The Human Subjects Committee at the University of Washington approved the study. Study Population Eligible case-patients had to be 18 years of age or older and to have had a spontaneous subarachnoid hemorrhage. Patients whose bleedings were found to originate from a source other than an intracranial aneurysmincluding primary intraparenchymal hemorrhages, arteriovenous malformations, trauma, and neoplasmswere excluded, but those in whom an aneurysm could not be identified were included. Because of the eligibility criteria for controls (described below), patients who did not have a telephone or who did not speak English were excluded. Case-patients were identified through a surveillance system that relied most heavily on the physicians and hospitals but also included the emergency medical systems serving the area and the King County medical examiner. Eligible patients were invited by their treating physician to participate in the study. Whenever possible, this invitation was directed to the patient, but because of death or disability, it often had to be directed to a family member or friend who was asked to act as the patient's surrogate or proxy. We identified controls using random-digit telephone dialing [7, 8]. They were matched to each case-patient by sex and age within 5 years. Once an appropriately matched control was identified, he or she was invited to participate in the study and to identify a proxy who would also be willing to participate. Two matched controls and their proxy respondents were identified for each case-patient. Potential controls who did not speak English were excluded. Data Collection Information on previous exposures was collected during a structured in-person interview. The interview was usually conducted in the participant's home and was completed in about 1 hour. Some of the questions were linked to a reference time. For the case-patients, the reference was when the initial subarachnoid hemorrhage occurred. For the controls, the reference was the same time of day and day of week as that of their matched case-patient but in the week before the interview of the control. As described previously [3], participants were questioned about their lifetime use of cigarettes, about their use of alcohol and stimulant drugs in the year before the reference date, and whether a physician had ever told them that they had hypertension. Detailed information was also collected from women on their lifetime use of medications containing estrogens and progestins, time from their last menstruation to the reference date, and weight and height. A personalized calendar was used to record major life events to assist recall. Photographs of all oral contraceptives and other hormone preparations ever marketed in the United States were also shown to all respondents. Whenever possible, the case-patient was interviewed, but the proxy for the case-patient, the two matched controls, and the proxies for the controls were always interviewed. Data Analyses Analyses in this report were limited to women who had had a subarachnoid hemorrhage and their age- and sex-matched controls. When the case-patient was able to provide information on exposure, interviews obtained directly with the two matched controls were used for comparison. When this was not possible, the proxy for the case-patient and the proxies for the two matched controls were used. The effects of exposures were assessed using conditional logistic regression [9], which takes into account the matching on age and respondent type (index compared with proxy); odds ratios and their 95% confidence intervals were also derived. Potential effect-modifying or confounding variables were evaluated using conditional logistic regression. Effect modification was assessed by examining stratum-specific odds ratios and the statistical significance of interaction terms. The extent of confounding was assessed by comparing the crude odds ratio derived from a model that did not contain the potential confounding variable with the adjusted odds ratio derived from the model that did contain it. The effect of using information provided by proxy respondents for the primary exposures of interest was examined by computing odds ratios separately for the two strata: self-reported data and proxy-derived data. In accordance with standard methods for analyzing mixed index-proxy data sets [10], the difference in odds ratios between the two respondent strata was tested by including an interaction term between respondent type and the exposure. In none of the resulting models assessing main exposures were interaction terms for respondent type statistically different. Finally, the reliability of proxy information was evaluated using the degree of agreement between controls and their proxy respondents. These analyses excluded the 15 pairs of controls and their proxies who were interviewed in each others' presence. The statistic and intraclass correlation coefficient were used as measures of reliability [11, 12]. Results Study Participants During the 2-year study, 171 incident cases of subarachnoid hemorrhage were identified in King County. The annual incidence per 100 000 was 12.2 new cases in women per year, 6.5 new cases in men, and 9.4 new cases overall [3]. Detailed information on the evaluation, treatment, and outcome of these patients is described elsewhere [13]. One hundred forty-nine case-patients were enrolled after 11 were excluded and 11 refused to participate. Of the 466 eligible controls, 313 (67.1%) agreed to participate in the study and identified a willing proxy. Detailed evaluation of cigarette smoking, use of alcohol, and history of hypertension in the entire group is presented elsewhere [3]. In these analyses, sex was not an effect modifier. This report concentrates on the 103 female case-patients, who represent 69% of all 149 case-patients. Forty-eight case-patients themselves could be interviewed; the proxies were interviewed for the remaining 55 case-patients because 38 case-patients had died and 17 had become disabled. The mean ages of the 103 female case-patients and their 206 age- and sex-matched controls were 57.6 17.4 years and 57.4 16.9 years, respectively. Case-patients and controls were predominantly white and were similar with respect to marital status. Case-patients had received less formal education than had controls: 12.6 2.4 years compared with 13.5 2.5 years, respectively. Risk Factors Even after conditional logistic regression was used to control for potential residual confounding by age, premenopausal women were found to be at a lower risk for subarachnoid hemorrhage than postmenopausal women (odds ratio, 0.24; 95% CI, 0.09 to 0.68) (Table 1). Women who formerly or, even more so, currently received postmenopausal hormone replacement therapy were at a lower risk for subarachnoid hemorrhage than were women who had never received therapy (Table 1). Longer duration of use and more recent use were associated with lower risk (for trend, P < 0.002 for both). Table 1. Risk for Subarachnoid Hemorrhage in Women Associated with Hormonal Factors The use of oral contraceptives was also associated with a reduced risk for subarachnoid hemorrhage that was not statistically different (Table 1). Case-patients who had never used oral contraceptives and those who formerly used them were combined as the reference group; in women who currently received oral contraceptives, the odds ratio was 1.5 (CI, 0.4 to 5.6). Findings were similar for oral contraceptive use between 1960 and 1970, when estrogen doses were higher, and oral contraceptive use between 1971 and 1990; the reduced risk was not significantly related to duration of use or time since last use (data not shown). Body mass index was calculated as weight in kilograms divided by height in meters squared. As shown in Table 1, the relation between body mass index and the risk for subarachnoid hemorrhage was U-shaped but was not significantly different as described previously [14, 15]. Hypertension, smoking, and age did significantly modify the effect of some hormonal factors (Table 2). Being premenopausal had a stronger negative association among women without a history of hypertension than among those with a history of hypertension. The reduced risk associated with being premenopausal was also much greater among those who had never smoked than those who had smoked. Interestingly, the reduced risk associated with hormone replacement therapy was evident only among women who had ever smoked, not among those who had never smoked, and was greatest in women aged 45 to 64 years compared with those younger or older. Table 2. Variables Modifying the Relation between Hormonal Factors and the Risk for Subarachnoid Hemorrhage Age, race, education, cigarette smoking, alcohol use, and hypertensive status were not found to be important confounding variables for the other hormonal factors. In addition, the effects of hormone replacement therapy and oral contraceptive use were not substantially altered by controlling for menopausal status. Twenty-eight women had a subarachnoid hemorrhage before menopause. The time of the last menstrual period was